VolitionRX Ltd is a US-based multi-national life sciences company. It is engaged in developing easy to use blood-based tests to accurately diagnose a range of cancers. The development pipeline includes assays to be used for symptomatic patients or asymptomatic populations. The company has developed more than 30 blood-based assays to detect specific biomarkers. It also develops Nucleosomics tests for several major cancers including CRC, pancreatic, lung and aggressive prostate. In addition, the company engages in the process of developing HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help decide the appropriate therapy.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.120 | 0.0000 | ||||
| REV | 10.000K | 25.530K | 15.530K |
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.100 | -0.110 | -0.0100 | ||||
| REV | 7.120K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VNRX | VolitionRX | 0% | 166.1M |
VolitionRX Company Questions & Answers
Q
How do I buy VolitionRX (VNRX) stock?
A
You can purchase shares of VolitionRX (AMEX: VNRX) through any online brokerage.
Q
Who are VolitionRX's (VNRX) main competitors?
A
There are no as such competitors for VolitionRX.
Q
What is the target price for VolitionRX?
A
The latest price target for VolitionRX (AMEX: VNRX) was reported by Cantor Fitzgerald on 2021-03-10. The analyst firm set a price target for 8.00 expecting VNRX to rise to within 12 months (a possible 154.78% upside). 3 analyst firms have reported ratings in the last year.
Q
How much is VolitionRX (VNRX) stock ?
A
The stock price for VolitionRX (AMEX: VNRX) is $3.14 last updated Tue May 11 2021 19:59:35 GMT+0000 (Coordinated Universal Time).
Q
When is the next VolitionRX (VNRX) dividend?
A
There are no upcoming dividends for VolitionRX.
Q
When is VolitionRX (AMEX:VNRX) reporting earnings?
A
VolitionRX’s Q2 earnings are confirmed from now on August 12, 2021.
Q
When is the upcoming split for VNRX?
A
There is no upcoming split for VolitionRX.